1. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
  • Belén Gutiérrez Gutiérrez; Robert A Bonomo; Yehuda Carmeli; David L Paterson; Benito Almirante; Luis Martínez Martínez; Antonio Oliver; Esther Calbo; Carmen Peña; Murat Akova; Johann Pitout; Julia Origüen; Vicente Pintado; Elisa García Vázquez; Oriol Gasch; Axel Hamprecht; Nuria Prim; Mario Tumbarello; German Bou; Pierluigi Viale; Evelina Tacconelli; Manel Almela; Federico Pérez; Helen Giamarellou; José Miguel Cisneros; Mitchell J Schwaber; Mario Venditti; Warren Lowman; Joaquín Bermejo; Po-Ren Hsueh; Marta Mora Rillo; Irene Gracia Ahulfinger; Alvaro Pascual; Jesús Rodríguez Baño and investigators from the REIPI/ESGBIS/INCREMENT Group J Antimicrob Chemother. 2016 Feb 22. pii: dkv502.
  1. β-Lactam/β-lactamase inhibitors combinations for the treatment of bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: a multinational, pre-registered cohort study.
  • Belén Gutiérrez Gutiérrez; Salvador Pérez Galera; Elena Salamanca; Marina de Cueto; Esther Calbo; Benito Almirante; Pierluigi Viale; Antonio Oliver; Vicente Pintado; Oriol Gasch; Luis Martínez Martínez; Johan Pitout; Murat Akova; Carmen Peña; José Molina; Alicia Hernández; Mario Venditti; Nuria Prim; Julia Origüen; German Bou; Evelina Tacconelli; Mario Tumbarello; Axel Hamprecht; Helen Giamarellou; Manel Almela; Federico Pérez; Mitchell J Schwaber; Joaquín Bermejo; Warren Lowman; Po-Ren Hsueh; Marta Mora Rillo; Clara Natera; Maria Solui; Robert A. Bonomo; Yehuda Carmeli; David L. Paterson; Alvaro Pascual; Jesús Rodríguez Baño and investigators from the REIPI/ESGBIS/INCREMENT Group.
  • Antimicrobial Agents and Chemotherapy (AAC): Accepted for publication (24/4/2016)
  1. A predictive model of mortality in patients with bloodstream infection due to carbapenemase-producing
  • Belén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, Po-Ren Hsueh, Pierluigi Viale, José Ramón Paño-Pardo, Mario Venditti, Mario Tumbarello, George Daikos, Vicente Pintado, Yohei Doi, Felipe Francisco Tuon, Ilias Karaiskos, Isabel Machuca, Mitchell J. Schwaber, Özlem Kurt Azap, Maria Souli, Emmanuel Roilides, Spyros Pournaras, Murat Akova, Federico Pérez, Joaquín Bermejo, Antonio Oliver, Manel Almela, Warren Lowman, Benito Almirante,  Robert A. Bonomo, Yehuda Carmeli, David L. Paterson, Alvaro Pascual, Jesús Rodríguez-Baño ,and investigators from the REIPI/ESGBIS/INCREMENT Group
  • Mayo Clinic Proceedings: In peer review
  1. Predictive model of 30-day mortality in a cohort of patients with bacteraemia due to extended spectrum beta-lactamases producing Enterobacteriaceae (ESBL-E): The INCREMENT Project.
  • Palacios-Baena Z., Gutiérrez-Gutiérrez B, et al.
  • Writing in process
  1. Monotherapy vs combined therapy in bacteraemia due to carbapenemase-producing Enterobacteriaceae.
    • Salamanca E., Gutiérrez-Gutiérrez B, et al.
    • Writing in process
  1. Targeted therapy in bacteraemic urinary tract infections due to carbapenemase-producing Enterobacteriaceae.
  • Pérez-Nadales; Belén Gutiérrez Gutiérrez, et al.
  • Writing in process.